1. Home
  2. CCO vs VOR Comparison

CCO vs VOR Comparison

Compare CCO & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.40

Market Cap

1.2B

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$18.88

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCO
VOR
Founded
1995
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
CCO
VOR
Price
$2.40
$18.88
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
$2.43
★ $39.00
AVG Volume (30 Days)
★ 4.2M
1.2M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
★ 23.24%
N/A
EPS Growth
★ 110.81
N/A
EPS
★ N/A
N/A
Revenue
★ $1,604,140,000.00
N/A
Revenue This Year
$7.33
N/A
Revenue Next Year
$2.33
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 6.57
N/A
52 Week Low
$1.27
$6.50
52 Week High
$2.44
$34.63

Technical Indicators

Market Signals
Indicator
CCO
VOR
Relative Strength Index (RSI) 56.08 39.48
Support Level $2.37 $13.35
Resistance Level $2.41 $24.23
Average True Range (ATR) 0.02 1.28
MACD 0.00 -0.33
Stochastic Oscillator 81.25 22.54

Price Performance

Historical Comparison
CCO
VOR

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: